Financial Performance - Revenue for Q3 2025 rose by 7.4% to $428.67 million compared to Q3 2024[7] - Profit attributable to equity holders increased by 0.8% year-on-year to $82.50 million in Q3 2025[7] - Revenue for the first nine months of 2025 grew by 11.4% to $1,234.68 million compared to the same period in 2024[8] - Profit attributable to equity holders for the first nine months of 2025 rose by 19.6% to $264.30 million[8] - Basic earnings per share for Q3 2025 decreased by 4.5% to 2.13 cents[7] Throughput Statistics - Total throughput increased by 4.2% year-on-year to 38,981,544 TEUs in Q3 2025[6] - Total throughput for the first nine months of 2025 increased by 5.6% to 113,277,515 TEUs[6] - Non-controlling terminal throughput rose by 5.8% year-on-year to 30,420,785 TEUs for the three months ended September 30, 2025, accounting for 78.0% of total throughput[14] - The controlling terminal throughput decreased by 0.9% year-on-year to 8,560,759 TEUs for the three months ended September 30, 2025[14] - The company's total container throughput for the first nine months of 2025 was 113.28 million TEUs, representing a year-on-year growth of 5.6%[24] Regional Performance - In China, total terminal throughput increased by 3.1% year-on-year to 29,502,970 TEUs, representing 75.7% of total group throughput[15] - The Bohai Rim region's total throughput rose by 5.1% year-on-year to 13,542,749 TEUs, accounting for 34.7% of total throughput[16] - The Southwest Coast region's total throughput increased by 10.7% year-on-year to 2,489,600 TEUs, with equity throughput rising by 12.6% to 526,146 TEUs[20] - The Yangtze River Delta region's total throughput increased by 1.9% year-on-year to 4,351,648 TEUs, with equity throughput rising by 0.3% to 1,247,595 TEUs[17] - The throughput in the Bohai Rim region increased by 5.7% year-on-year, totaling 39.38 million TEUs for the first nine months of 2025[24] Asset and Liability Overview - Total assets as of September 30, 2025, amounted to $12,794.99 million, up from $12,021.39 million in 2024[9] - Total liabilities increased to $5,423.77 million as of September 30, 2025, compared to $4,976.14 million in 2024[10] - Total equity as of September 30, 2025, was $7,371.22 million, an increase from $7,045.25 million in 2024[10] Strategic Focus and Future Plans - The company plans to focus on optimizing its global network layout and enhancing operational efficiency through digital empowerment[23] - The company aims to promote green and smart port construction, enhancing automation and operational scale[23] - The company is addressing external uncertainties by focusing on its core business and leveraging opportunities from global industrial chain upgrades[23] - The company is focused on strategic growth and market expansion despite recent declines in certain throughput categories[25] Cautionary Statements - The company advises shareholders and potential investors to exercise caution regarding the unaudited data presented for the three and nine months ending September 30, 2025[26] - The company emphasizes the importance of consulting professional advisors for personal investment situations[26] - The company is committed to transparency and accuracy in financial reporting, as indicated by the cautionary statement[26] - The board of directors includes various members, ensuring a diverse leadership structure[26] Trade and Market Context - In the first three quarters of 2025, the total import and export value of China's goods trade reached RMB 33.6 trillion, a year-on-year increase of 4.0%[22] - The World Trade Organization (WTO) has adjusted its global goods trade growth forecast for 2025 from 0.9% to 2.4%[22]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 2025年第三季度報告 本公告由新華人壽保險股份有限公司（「本公司」或「公司」）根據《證券及期貨條例》（香港 法例第571章）第XIVA部項下的內幕消息條文及《香港聯合交易所有限公司證券上市規 則》第13.09條及13.10B條作出。 本公司2025年第三季度報告所載財務資料根據中國企業會計準則編製，且未經審計。 重要內容提示： - 1 - • 本公司董事會、監事會及董事、監事、高級管理人員保證本報告內容的真實、準 確、完整，不存在虛假記載、誤導性陳述或重大遺漏，並承擔個別和連帶的法律責 任。 • 本公司董事長楊玉成先生，總裁、財務負責人龔興峰先生，總精算師潘興先生以及 會計機構負責人張韜先生保證本季度報告中財務信息的真實、準確、完整。 • 本公司2025年第三季度報告所載財務資料未經審計。 一、主要財務數據 （一） ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立之股份有限公司） （股份代號：1339） 2025年第三季度報告 本公告由中國人民保險集團股份有限公司（「本公司」或「公司」，連同其附屬公司，統稱 「本集團」或「集團」）根據《證券及期貨條例》（香港法例第571章）第XIVA部項下的內幕消 息條文及《香港聯合交易所有限公司證券上市規則》第13.09條及13.10B條作出。 重要內容提示： - 1 - • 本公司董事會、監事會及董事、監事、高級管理人員保證季度報告內容的真實、準 確、完整，不存在虛假記載、誤導性陳述或重大遺漏，並承擔個別和連帶的法律責 任。 • 本公司負責人、主管會計工作負責人及會計機構負責人（會計主管人員）保證季度報 告中財務報表信息的真實、準確、完整。 • 本公司2025年第三季度報告所載財務資料根據中國企業會計準則編製，且未經審 計。 一、主要財務數據 （一）主要會計數據和財務指標 | | | | 單位：百萬 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任 何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 中 國 農 業 銀 行 股 份 有 限 公 司 AGRICULTURAL BANK OF CHINA LIMITED （ 於 中 華 人 民 共 和 國 註 冊 成 立 之 股 份 有 限 公 司 ） （股份代號：1288） 2025年第三季度報告 中國農業銀行股份有限公司（「本行」）董事會（「董事會」）欣然宣佈本行及所屬子公司（統稱 「本集團」）截至2025年9月30日止第三季度期間按照國際會計準則委員會頒佈的《國際財 務報告會計準則》（「國際財務報告會計準則」）編製的未經審計業績。本公告乃根據香港 法例第571章《證券及期貨條例》第XIVA部及《香港聯合交易所有限公司證券上市規則》第 13.09(2)條及第13.10B條的要求做出。 一、公司基本信息 （二）主要會計數據、財務指標發生變動的情況、原因 以上主要會計數據、財務指標變動幅度未超過30%。 | A股股票上市交易所 | 上海證券交易所 | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03328） 2025年三季度業績公告 交通銀行股份有限公司（「本行」）董事會（「董事會」）欣然宣佈本行及其附屬公司 （「本集團」）截至2025年9月30日止九個月（「報告期」）的未經審計業績（「三季度業 績」）。本行董事會及其轄下的審計委員會已審閱並確認此三季度業績。本公告乃 根據《證券及期貨條例》（香港法例第571章）第XIVA部及香港聯合交易所有限公 司證券上市規則第13.09條而作出。 一、公司基本情況 | | 股票簡稱 | 股票代號 | 上市交易所 | | --- | --- | --- | --- | | A股 | 交通銀行 | 601328 | 上海證券交易所 | | H股 | 交通銀行 | 03328 | 香港聯合交易所有限公司 | | 境內優先股 | 交行優1 | 360021 | 上海證券交易所 | 董事會秘書、公司秘書 | 姓 ...

2024/2025 ANNUAL REPORT 年報 Contents 目錄 Corporate Information 2 公司資料 Five-Year Financial Summary 144 五年財務概要 Financial Highlights 5 財務摘要 Profile of Directors and Company Secretary 6 董事及公司秘書履歷 Management Discussion and Analysis 8 管理層討論及分析 Corporate Governance Report 14 企業管治報告 Report of the Directors 32 董事會報告 Independent Auditor's Report 45 獨立核數師報告 Consolidated Financial Statements 52 綜合財務報表 Notes to the Consolidated Financial Statements 57 綜合財務報表附註 Corporate Information 公司資料 BOARD OF DIRECTORS Executive Direct ...

（於開曼群島註冊成立之有限公司） Summi (Group) Holdings Limited 森美（集團）控股有限公司 股份代號：00756 健康 由森美開始 公司秘書 年度報告 2025 目錄 2 公司資料 3 財務摘要 4 主席報告 5 管理層討論及分析 10 董事會及高級管理層 12 董事會報告書 21 企業管治報告 35 獨立核數師報告 38 綜合損益及其他全面收益表 39 綜合財務狀況表 41 綜合權益變動表 43 綜合現金流量表 45 綜合財務報表附註 130 五年財務摘要 公司資料 董事 執行董事 吳紹豪先生 吳聯韜先生 （主席） 獨立非執行董事 鍾頴怡女士 楊許萍女士 彭韋豪先生（於二零二四年十月二十二日獲委任） 錢盈盈女士，CPA 授權代表 吳聯韜先生 錢盈盈女士，CPA 審核委員會 彭韋豪先生 （主席） （於二零二四年十月二十二日 獲委任） 鍾頴怡女士 楊許萍女士 薪酬委員會 彭韋豪先生 （主席） （於二零二四年十月二十二日 獲委任） 吳紹豪先生 鍾頴怡女士 楊許萍女士 提名委員會 楊許萍女士 （主席） 吳紹豪先生 鍾頴怡女士 投資及合規委員會 吳紹豪先生 （主席） 吳聯韜先生 楊許萍女 ...

02 Chairman's Message 主席的話 全球消費市場正經歷結構性變革，數字化浪潮重 塑商業格局，跨境電商開啟無國界零售新時代。在此 關鍵時刻，卓悅以遠見引領變革，以創新驅動轉型， 不僅緊握時代脈搏，更致力於定義未來零售的新模 式。我們以「科技+消費」為核心戰略，立足香港、服 務全球，構建面向未來的「四輪驅動」生態體系——跨 境樞紐（ 香港猫 ）、科技應用（ 卓悅科技 ）、美妝智造 （ 美顏產業 ）、產融結合（ 創新產業 ），為行業轉型提 供前瞻性解決方案。 前瞻佈局：從數字化轉型到生態化 引領 早於2020年，我們已洞悉傳統零售邊界將被打 破，率先啟動深層次戰略重構。憑藉香港「零關稅+ 高效清關」的獨特優勢，結合粵港澳大灣區的創新活 力，我們打造了「香港貓HKMALL」全球跨境電商平 台，作為未來發展的重要基礎設施。這一超前佈局， 推動卓悅從美妝零售商轉型為整合「跨境電商+智慧 物流+AI營銷」的數字化綜合生態，實現虛實深度融 合的創新商業模式。 我們期待人工智能將重塑零售業本質，率先引入 深度學習算法構建智慧供應鏈，並開發具自然語言處 理能力的智慧客服系統，大幅提升營運效率與用戶體 驗。卓悅始 ...

Financial Performance - Total revenue for the fiscal year ending June 30, 2025, decreased by 11.1% to approximately HKD 142,900,000 from HKD 160,700,000 in the previous fiscal year[15]. - Solar power business revenue was approximately HKD 52,600,000, down 15.0% from HKD 61,900,000 in the previous year[16]. - Revenue from the distribution system business was approximately HKD 88,700,000, a decrease of 10.3% from HKD 98,900,000 in the previous year[17]. - The beauty and wellness business generated revenue of approximately HKD 1,600,000, marking its first contribution to total revenue[13]. - The net income tax credit for the fiscal year ending June 30, 2025, was approximately HKD 1,300,000, compared to a net income tax expense of approximately HKD 1,500,000 for the fiscal year ending June 30, 2024[25]. - Total employee costs, including directors' remuneration, were approximately HKD 13,600,000 for the fiscal year ending June 30, 2025, down from HKD 17,900,000 in 2024[26]. - Total assets as of June 30, 2025, were approximately HKD 220,900,000, a decrease of 2.8% from HKD 227,300,000 in 2024[28]. - Total liabilities as of June 30, 2025, were approximately HKD 75,900,000, an increase of 0.5% from HKD 75,500,000 in 2024[28]. - Total equity decreased by 4.4% to approximately HKD 145,000,000 as of June 30, 2025, down from HKD 151,700,000 in 2024[29]. - The capital debt ratio was 0.49 as of June 30, 2025, compared to 0.27 in 2024[30]. - The group recorded a net cash outflow from operating activities of approximately HKD 15,100,000 for the fiscal year, an increase from HKD 1,200,000 in the previous year[49]. Cost Management - Gross profit margin improved to 6.8%, an increase of 83.8% from 3.7% in the previous fiscal year, primarily due to general price increases[19]. - Operating loss decreased to approximately HKD 18,100,000 from HKD 44,100,000 in the previous year, driven by increased gross profit and reduced administrative expenses[19]. - Administrative expenses decreased by 18.9% to approximately HKD 21,700,000 from HKD 26,700,000 in the previous year[22]. - Other operating expenses decreased to approximately HKD 700,000 for the fiscal year ending June 30, 2025, down from HKD 1,400,000 in 2024[24]. - Capital expenditure for the fiscal year ending June 30, 2025, was approximately HKD 3,600,000, a decrease from HKD 6,700,000 in the previous year[45]. Market and Business Strategy - The company is exploring opportunities in the third-generation photovoltaic products and semiconductor developments[9]. - The company remains confident in the Chinese market and will continue to focus on solar power and distribution systems while seeking new developments[14]. - The company aims to enhance shareholder value by pursuing projects with stable returns and high growth potential[9]. - The group faces credit risk primarily from trade receivables, with major customers accounting for approximately 61% and 65.1% of total trade receivables as of June 30, 2025, and June 30, 2024, respectively[55]. - The group has a project duration ranging from 6 to 48 months, and any delays may adversely affect revenue and financial performance due to increased costs[55]. - The group is exposed to risks from changes in government policies regarding renewable energy, which could limit revenue and profitability if subsidies are reduced[58]. Corporate Governance - The company has a commitment to high corporate governance standards, adhering to the principles of the Corporate Governance Code as per the Hong Kong Stock Exchange[117]. - The company has not entered into any management or administrative contracts for significant portions of its business for the fiscal year ending June 30, 2025[72]. - The company has complied with the disclosure requirements under Chapter 14A of the Listing Rules for the fiscal year ending June 30, 2025[78]. - The company has established procedures for directors to seek independent professional advice at the company's expense when necessary[128]. - The board consists of three executive directors and four independent non-executive directors as of June 30, 2025[124]. - The company has established a system for shareholders to submit inquiries and suggestions to the board through the company secretary[158]. Environmental and Social Responsibility - The company aims to reduce greenhouse gas emissions and other pollutants through various initiatives, including energy-saving lighting and encouraging public transport[168]. - The company reported emissions of sulfur oxides (SOx) at 0.03 kg, nitrogen oxides (NOx) at 1.2 kg, and particulate matter (PM) at 0.1 kg for the fiscal year ending June 30, 2025[171]. - The company generated 10.4 tons of CO2 emissions for the year ending June 30, 2025, compared to 23.1 tons in 2024, indicating a significant reduction[172]. - The company consumed 7,203 kWh of electricity in 2025, down from 31,277 kWh in 2024, resulting in a decrease in energy-related CO2 emissions from 12.8 tons to 3.0 tons[174]. - The company has not recorded any workplace injuries or fatalities in the past three years, ensuring a safe working environment[195]. - The company encourages employees to reuse paper and implement double-sided printing to reduce paper consumption, with total paper usage decreasing from 123 kg in 2024 to 111 kg in 2025[174]. Employee and Training Initiatives - 90% of general employees and 21% of management participated in training programs, with an increase to 96% and 27% expected in 2024[196]. - Average training hours for general employees increased from 11 hours in 2024 to over 15 hours in 2025, with male employees averaging 15 hours[196]. - The company has maintained a stable workforce of 35 full-time employees since 2024, with a gender ratio of approximately 1.3:1 in 2025[180][191]. - The company promotes a diverse workforce, with approximately 37% of employees being 35 years old or younger in 2025, up from 34% in 2024[193].

Financial Performance - The company achieved a profit attributable to shareholders growth of approximately 8.9% compared to the fiscal year 2024, reflecting prudent strategies and operational rigor[10]. - The company recorded a revenue of approximately HKD 644.4 million for the fiscal year 2025, representing an increase of about 9.1% compared to HKD 590.8 million in fiscal year 2024[19]. - The net profit attributable to the company’s owners for fiscal year 2025 was approximately HKD 26.3 million, an increase of about HKD 2.1 million or 8.9% compared to fiscal year 2024[33]. - The effective tax rate increased from approximately 8.9% in fiscal year 2024 to about 11.1% in fiscal year 2025, due to an increase in taxable income[30]. - The group achieved a profit attributable to shareholders growth of approximately 8.9% year-on-year for the fiscal year 2025[34]. Revenue Growth by Division - Revenue from primary care services increased by approximately HKD 12.4 million or 3.1% to about HKD 410.8 million in fiscal year 2025, driven by an increase in patient visits and average spending per visit[19]. - Revenue from specialist medical services rose by approximately HKD 31.9 million or 23.8% to about HKD 165.8 million in fiscal year 2025, attributed to higher patient visits and average spending[20]. - Revenue from dental services increased by approximately HKD 9.3 million or 15.9% to about HKD 67.8 million in fiscal year 2025, mainly due to increased patient visits following the acquisition of a dental practice[20]. - The primary care division's revenue increased by about 3.1% compared to fiscal year 2024, maintaining stable performance[37]. - The specialty medical division generated revenue of approximately HKD 165.8 million in fiscal year 2025, representing a year-on-year growth of about 23.8%[39]. - The dental division's revenue, including the acquisition of Youde Dental, reached approximately HKD 67.8 million, reflecting a year-on-year increase of about 15.9%[41]. Strategic Initiatives and Expansion - The company plans to expand its primary care network by opening new medical centers and investing in digital platforms to enhance data management and customer engagement[16]. - The group has strategically opened new medical centers in Tsuen Wan, Tsim Sha Tsui, and Causeway Bay to improve accessibility and strengthen its presence in key areas[37]. - The group plans to enhance its specialized medical services, particularly in ophthalmology under the POLYEYE brand, by introducing new surgical techniques and hiring more professionals[66]. - Following the acquisition of Youde Dental, the group aims to strengthen its position in the dental services market and expand its service offerings[66]. - The group continues to maintain partnerships with the Hong Kong government, actively participating in various public health initiatives and community wellness programs[69]. Digital Transformation and Technology Integration - Digital transformation was a core focus, with the implementation of an integrated clinic operation system and a full-service marketing platform across most medical centers[14]. - The group achieved significant progress in digital transformation, implementing a comprehensive clinic operation system and a full-channel marketing platform to enhance customer engagement and satisfaction[46]. - The group integrates technology into operations to enhance care quality and efficiency, reflecting its commitment to improving healthcare services[46]. - The group will implement a comprehensive clinic operation system and a full-access marketing platform across most medical centers in fiscal year 2025, significantly improving clinical workflow coordination and appointment handling[67]. Community Health and Preventive Care - The company maintained close collaboration with the Hong Kong government on community health programs, highlighting its role in supporting healthcare infrastructure[15]. - The company emphasized preventive care and health education, promoting comprehensive health check-up packages through its health management center and online channels[13]. - The group continues to emphasize preventive care through advanced diagnostic health check packages and vaccination services[45]. - The flagship health center, H2, continues to enhance community health awareness through health seminars and workshops[43]. Human Resources and Talent Management - The professional team consists of 431 members, including general practitioners, specialists, and various healthcare professionals, ensuring comprehensive and patient-centered care[62]. - The company emphasizes the importance of attracting and nurturing professional talent to meet the growing patient demand and enhance its cross-departmental collaboration[68]. - The shortage of qualified healthcare professionals is a key issue impacting the healthcare industry, complicating recruitment and retention efforts[186]. - The group's financial performance may be affected if it fails to recruit or retain qualified professionals, as its business model relies on these teams[187]. Corporate Governance and Board Structure - The company has adopted the corporate governance code as its governance framework and has complied with all applicable code provisions for the fiscal year 2025, except for a deviation regarding the separation of the roles of Chairman and CEO[113][114]. - The board consists of six members, including three executive directors and three independent non-executive directors[120]. - The company has established procedures for directors to seek independent advice at reasonable requests, with costs borne by the company[119]. - The company has a policy for directors to retire and seek re-election at least every three years[130]. - The board has mechanisms to address conflicts of interest during decision-making processes[129]. Financial Position and Assets - The group’s net current assets as of June 30, 2025, are approximately HKD 383.9 million, a decrease from HKD 397.8 million as of June 30, 2024[73]. - The group’s interest-bearing bank borrowings as of June 30, 2025, amount to approximately HKD 16.8 million, with a mortgage loan of HKD 8.2 million due in 2036[73]. - The capital debt ratio as of June 30, 2025, is approximately 2.1%, down from 4.0% as of June 30, 2024[74]. - The company’s distributable reserves amounted to approximately HKD 206.7 million, with about HKD 11.4 million recommended for the final dividend[181]. Shareholder Communication and Dividends - The company proposed a final dividend of HKD 0.03 per share for the fiscal year 2025, an increase from HKD 0.028 in fiscal year 2024[176]. - The company maintains effective communication with shareholders through various channels, including interim and annual reports[169]. - The board is committed to ensuring that shareholders can access timely information to exercise their rights and participate in company affairs[168]. - The company has adopted a dividend policy that will be reviewed annually by the board, aiming to provide stable and sustainable returns to shareholders[171]. Industry Challenges and Risks - The group faces strategic risks due to rapidly changing community demands and ongoing global economic uncertainties post-pandemic[186]. - The group emphasizes the importance of maintaining a good reputation in the healthcare sector, as negative news could adversely affect its brand image[188]. - The group has not purchased, sold, or redeemed any of its listed securities in the fiscal year 2025[194].